BD1 Outlook, page-91

I think management has set the CR price exactly as they told us they would. No surprises at all really. I agree that it could have been considered at 3c or more and many of us would have still taken it but the underwriter might not have been as keen on that idea of course as it would have exposed them to a higher level of risk.
With CR prices surprises are not good either way I suppose. My popcorn is set waiting for the current drift to end. Fully agree with your thoughts on "The test products are world class and the highest results so far". Test Commercialization is not drug development. So much simpler. Your RHT had a great kick last week. (unless your holding from early 2015) Todays 30% would put a smile on your dial!

Have a great night everyone. Sushi for me with a run later. Not to the loo promise.